濮阳东方医院咨询大夫濮阳东方男科医院割包皮口碑怎么样,濮阳东方医院看妇科口碑很高,濮阳东方看男科技术很靠谱,濮阳东方妇科预约挂号,濮阳东方男科非常可靠,濮阳东方医院割包皮好不好,濮阳东方妇科医院收费低吗

We're about a month into the school year and teachers are struggling to keep children up to speed amid the pandemic.We spoke with a principal at an elementary school in Arizona who says students are about five to six months behind. Some kids who should be reading by now, simply are not.She says when you think about it, most students have not been inside a classroom since March.One challenge for teachers has been teaching at-home students and giving one-on-one attention to those in the classroom. The other challenge has been technology.“It’s day to day, whether or not technology works,” said principal Sarah Lewis. “And if you think about it, we've been hybrid for about three weeks now, but before that, we were all digital learning. We would have full days where we wouldn't have any technology, so basically we would have to tell the kids, go into Google Classroom and practice your multiplication facts.”Lewis says it's tough to hear young kids are learning on their parents’ cell phones, because they don't have a computer.However, she says she's proud of how fast teachers became tech savvy, as well as the level of understanding from most parents and their willingness to be flexible. She's also proud of the kids.“Five-year-olds do not understand that you cannot go over to your friend’s desk and ask what they're reading or coloring, but as far as wearing the mask and being OK when we ask them to step away or ask them to, I mean it's incredible that little kids are able to do it,” said Lewis.Lewis says she wants people to know just how difficult it is for teachers to balance teaching online students and those in the classroom. She says many are fearful of the pandemic, but realize they have a job to do. 1733

WAUWATOSA, Wis. — A 3-year-old in Wisconsin can see for the first time thanks to a new procedure.  McKinley Sovey is the youngest person to undergo this type of gene therapy. Her parents Parker and Julie Sovey have been watching her progress."There was that moment when she did look at me for the first time," said Julie. "I was like I think this is working. I can't even really explain it.  She's 3 years old and she looks at mom for the first time. It was a really really cool moment and it was the moment I was waiting for."McKinley was born practically blind. The most she could see was the contrast of light. When she was a year and a half, doctors discovered she inherited a retinal disease.  "Six months after that FDA approval, and then less than a year after that she's having the procedure, so it's been like rapid fire," Parker said. Dr. Stephen Russell works in the Department of Ophthalmology and Visual Sciences at the University of Iowa Hospital. He performed both of McKinley's eye surgeries with the gene therapy earlier this month.  "Complicated drug because it has multiple parts to the drug and complicated surgery because to make sure we delivered the drug to the appropriate tissues," said Russell.Russell said he is basically forcing DNA into the right cell."We had to do a surgery just to put the solution in the appropriate spot, which is in the area underneath the retina," he said. "At that point, it's just fingers crossed that this gene ends up in the spot that it's supposed to," said Julie.The Soveys knew there were risks and potential complications.  "It's terrifying," said Russell.They were hoping the therapy would at least help McKinley maintain the little vision she had. After the first eye surgery, mom and dad didn't notice a difference. But it was shortly after the second surgery they knew it worked. Parker said she was moving with a purpose."She walked into the kitchen, pulled a chair out, stood up on the chair and actively feeling like the toaster and the coffee maker like she knew those were there and she wanted to get up and be able to feel them," he said.McKinley's depth perception is also changing."Being able to see things further away has been really neat and it's also been kind of scary because I feel like I'm having to re-childproof the house for a 3-year-old," said Julie."She use to feel around for whatever it was she was eating," Parker said. "Then she'd put her hands in it to see what it was and then she'd put the spoon in it, and then usually it was dumped by the time it got to her face."McKinley will still likely be visually impaired, but her parents said any progress is a bonus."She may no longer need to be a braille reader," Julie said. "I don't know if she'll need to use a cane to navigate."They said their daughter is becoming more confident and her personality is even changing."This is kind of part of medical history," said Julie.McKinley has some checkups scheduled, but doctors hope she won't need another surgery. 3071

We are incredibly saddened that one of our Adventuredome guests was injured and our hearts go out to the guest and her family. Safety is our top priority, and the ride in question is closed until further notice as this incident is investigated. 252

WASHINGTON, D.C. – Two different doses of a thyroid medication are being recalled because they're not potent enough.The Food and Drug Administration announced Thursday that Acella Pharmaceuticals is voluntarily recalling one lot of 15-milligram and one lot of 120-milligram NP Thyroid?, Thyroid Tablets.The products may have as low as 87% of the labeled amount of levothyroxine, which is used to treat hypothyroidism (an underactive thyroid), according to the FDA.The company’s risk statement says patients being treated for hypothyroidism who receive sub potent NP Thyroid may experience symptoms of hypothyroidism, including fatigue, increased sensitivity to cold, constipation, dry skin, puffy face, hair loss, slow heart rate, depression, swelling of the thyroid gland and/or unexplained weight gain or difficulty losing weight.“There is reasonable risk of serious injury in newborn infants or pregnant women with hypothyroidism including early miscarriage, fetal hyperthyroidism, and/or impairments to fetal neural and skeletal development,” wrote Acella. “In elderly patients and patients with underlying cardiac disease toxic cardiac manifestations of hyperthyroidism may occur, such as cardiac pain, palpitations or cardiac arrhythmia.”So far, Acella says it has received four reports of "adverse events" for these lot numbers, possibly related to the recall.The products subject to recall are packed in 100-count bottles. Their lot numbers are M327E19-1 and M328F19-3. And their expiration dates are Oct. 2020 and November 2020.The products were distributed nationwide to Acella’s direct accounts, including wholesalers, pharmacies, and health care offices.“Acella is proactively notifying its wholesalers by email and phone to discontinue distribution of the two above referenced lots being recalled and is arranging for return of all recalled products,” wrote the company.Anyone who is currently taking NP Thyroid from the lots being recalled should not discontinue use without contacting their health care provider for further guidance and/or a replacement prescription, according to Acella.Anyone with questions about the recall can email Acella at recall@acellapharma.com or contact a representative at 1-888-280-2044.Click here for more information. 2272

WEEKI WACHEE, Fla. — Searing pain and immediate swelling were the first signs that 6-year-old Kyden Debyah needed immediate medical attention.While playing in his backyard Monday morning, Kyden said he felt what he thought was a bee sting his right foot near his big toe. Then his mom saw a snake coiled up underneath the tire swing Kyden was about to get on.“I heard him scream 'My leg, my leg,'” Amber Debyah said. Debyah called 911 and grabbed a rake to kill the snake. By the time she came back she said she knew it was bad.“His foot was double the size. It was really hot, red,” Debyah said.First responders told her to try and get the snake so they could identify it and figure out what type of antivenin he needed. First responders brought the dead snake to the emergency room and doctors began administering antivenin for a pygmy rattlesnake bite. In all, Kyden got 18 vials before the swelling subsided and his symptoms started to go away.  The entire time Debyah worried if her son would lose his leg or worse.“I really feel he got lucky after reading other people's stories,” Debyah said. “I feel like if it would have bit him fully with both fangs, it would’ve been a lot worse.”Only one fang injected venom into Kyden’s body. “He was in great spirits the whole time. He was laughing and joking I mean other than the pain in his foot he had no symptoms, no fever, no vomiting. Normal Kyden, except for the pain,” Debyah said.  Kyden might have a low-grade fever, sore joints, rashes, but nothing that will cause permanent damage, Debyah said. Each vial of antivenin costs around ,000. The family has insurance but it does not cover snake bites. The insurance company said their contracted cost for the antivenin will be adjusted but could be anywhere from ,000 to ,000.Kyden is still allowed to play in the backyard, with one new rule, he keeps his boots on at all times.“So grateful", Kyle Debyah, Kyden’s dad said. “You want to try and be strong and focused to better assess everything but I was worried.”The family set up a Gofundme if you would like to help them cover the cost of the antivenin. To donate, click here. 2206